Celyad Oncology SA: Celyad Oncology to Announce Full Year 20

Regulatory News: Celyad Oncology SA (Euronext Nasdaq: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric

Related Keywords

Mont Saint Guibert , Waals Gewest , Belgium , New York , United States , Walloon Region , Paris , France General , France , Brussels , Bruxelles Capitale , Sara Zelkovic , Exchange Commission , Communications Investor Relations , Lifesci Advisors , Regulatory News , Euronext Nasdaq , Private Securities Litigation Reform Act , Celyad Oncology , Annual Report , Media Contacts , Investor Relations Director , Sci Advisors , Celyad , Ncology , Nnounce , Bull , Ear , 021 , Financial , Results , Most , Conference , Wall ,